ANG-mediated targeting and/or retention in glioma brain could account for the substantial amount of w-MWNT-ANG (~ 0.8%ID/g) measured at 24 h post-injection compared to non-targeted w-MWNT (~ 0.38%ID/g). The gene discussed is ANG; the disease is central nervous system cancer.